Multi-kinase-IN-14

Overview

Multi-kinase-IN-14 is an orally active and blood-brain barrier-permeable multi-kinase inhibitor. Multi-kinase-IN-14 reduces the excessive phosphorylation of α-synuclein by inhibiting four kinases ( ABL1 , DYRK1A , GSK3β , and LRRK2 ) and stabilizing microtubules. Multi-kinase-IN-14 is applicable for research on neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Parkinson's Disease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Bcr-Abl | Products > Signaling Pathways > GSK-3 | Products > Signaling Pathways > DYRK | Products > Signaling Pathways > LRRK2 | Products > Signaling Pathways > Microtubule/Tubulin | Products > Signaling Pathways > α-synuclein

Product Information

• Catalog No.: HY-181046
• CAS No.: 2201083-51-2
• Molecular Formula: C17H14ClN5
• Molecular Weight: 323.78
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source